Abstract
An alcoholic woman who was admitted to hospital for detoxification was prescribed thyroxine because of hypothyroidism and mianserin to alleviate severe depression. After several weeks' treatment she became unwell and was readmitted to hospital. Haematological examination indicated agranulocytosis. Further extensive investigations elicited no cause for this other than the mianserin, since no such disturbance has been reported for thyroxine after years of use. Thus mianserin is probably implicated in this case of agranulocytosis. Although the response may have been idiosyncratic, it highlights the need to monitor new drugs during the early phases of widespread use.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Coppen A., Gupta R., Montgomery S., Ghose K., Bailey J., Burns B., de Ridder J. J. Mianserin hydrochloride: a novel antidepressant. Br J Psychiatry. 1976 Oct;129:342–345. doi: 10.1192/bjp.129.4.342. [DOI] [PubMed] [Google Scholar]
- Crome P., Newman B. Poisoning with maprotiline and mianserin. Br Med J. 1977 Jul 23;2(6081):260–260. doi: 10.1136/bmj.2.6081.260-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Murphy J. E., Donald J. F., Molla A. L. Mianserin in the treatment of depression in general practice. Practitioner. 1976 Jul;217(1297):135–138. [PubMed] [Google Scholar]
- Wheatley D. Controlled clinical trial of a new antidepressant (Org. GB 94) of novel chemical formulation. Curr Ther Res Clin Exp. 1975 Dec;18(6):849–854. [PubMed] [Google Scholar]